Analysis assesses importation risk of Nipah virus from affected countries to China, highlighting necessary public health strategies.
What is already known about this topic? Nipah virus (NiV) is a highly lethal zoonotic pathogen. Its re-emergence in India in early 2026 has heightened global public health concerns. What is added by this report? This study systematically assessed the risk of NiV importation into China from five affected countries. India and Bangladesh posed moderate importation risks, whereas Malaysia, the Philippines, and Singapore presented low risks. What are the implications for public health practice? The findings emphasize that coupling existing defenses with sustained multi-source surveillance and dynamic risk modeling is essential to mitigate risks of stochastic NiV entry.
No takes yet. Share an insight, caveat, or question.
Weijing et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: